Similar articles for PMID: 33622892

Year	Number of Results
2004	1
2005	2
2006	3
2007	1
2008	2
2011	5
2012	4
2013	4
2014	8
2015	6
2016	7
2017	8
2018	11
2019	13
2020	13
2021	22
2022	16
2023	3
2024	0

1

Retrospective Comparison of mFOLFOXIRI With XELOX/SOX as Neoadjuvant Chemotherapy for Locally Advanced Rectal Cancer.

Kodama H, Terazawa T, Ishizuka Y, Yukami H, Aoki M, Miyamoto T, Yamaguchi T, Shimamoto F, Kii T, Goto M, Hamamoto H, Osumi W, Yamamoto M, Tanaka K, Okuda J, Uchiyama K, Higuchi K. Kodama H, et al. In Vivo. 2021 Mar-Apr;35(2):977-985. doi: 10.21873/invivo.12340. In Vivo. 2021. PMID: 33622892 Free PMC article.

2

Neoadjuvant Chemotherapy With mFOLFOXIRI Without Routine Use of Radiotherapy for Locally Advanced Rectal Cancer.

Zhang J, Huang M, Cai Y, Wang L, Xiao J, Lan P, Hu H, Wu X, Ling J, Peng J, Chen D, Kang L, Zhang Y, Ren D, Wang H, Chen S, Lin F, Zheng J, Zhou Z, Wang J, Deng Y. Zhang J, et al. Clin Colorectal Cancer. 2019 Dec;18(4):238-244. doi: 10.1016/j.clcc.2019.07.001. Epub 2019 Jul 11. Clin Colorectal Cancer. 2019. PMID: 31378655 Clinical Trial.

3

mFOLFOXIRI versus mFOLFOX6 as neoadjuvant chemotherapy in locally advanced rectal cancer: A Propensity Score Matching Analysis.

Ding M, Zhang J, Hu H, Cai Y, Ling J, Wu Z, Xie X, Li J, Li W, Deng Y. Ding M, et al. Clin Colorectal Cancer. 2022 Mar;21(1):e12-e20. doi: 10.1016/j.clcc.2021.11.009. Epub 2021 Nov 28. Clin Colorectal Cancer. 2022. PMID: 34963563

4

Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched study.

Li A, Huang T, Zheng R, Chi P, Li Z, Wang X, Xu B. Li A, et al. BMC Cancer. 2022 Jul 18;22(1):789. doi: 10.1186/s12885-022-09855-z. BMC Cancer. 2022. PMID: 35850711 Free PMC article.

5

Neoadjuvant sandwich treatment with oxaliplatin and capecitabine administered prior to, concurrently with, and following radiation therapy in locally advanced rectal cancer: a prospective phase 2 trial.

Gao YH, Lin JZ, An X, Luo JL, Cai MY, Cai PQ, Kong LH, Liu GC, Tang JH, Chen G, Pan ZZ, Ding PR. Gao YH, et al. Int J Radiat Oncol Biol Phys. 2014 Dec 1;90(5):1153-60. doi: 10.1016/j.ijrobp.2014.07.021. Epub 2014 Oct 13. Int J Radiat Oncol Biol Phys. 2014. PMID: 25442042 Clinical Trial.

6

Randomized phase II study comparing the efficacy and safety of SOX versus mFOLFOX6 as neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer (KSCC1301).

Miwa K, Oki E, Enomoto M, Ihara K, Ando K, Fujita F, Tominaga M, Mori S, Nakayama G, Shimokawa M, Saeki H, Baba H, Mori M, Akagi Y. Miwa K, et al. BMC Cancer. 2021 Jan 5;21(1):23. doi: 10.1186/s12885-020-07766-5. BMC Cancer. 2021. PMID: 33402130 Free PMC article. Clinical Trial.

7

Therapeutic effects of oxaliplatin-based neoadjuvant chemotherapy and chemoradiotherapy in patients with locally advanced rectal cancer: a single-center, retrospective cohort study.

Okuyama T, Sameshima S, Takeshita E, Yoshioka R, Yamagata Y, Ono Y, Tagaya N, Noie T, Oya M. Okuyama T, et al. World J Surg Oncol. 2018 Jun 5;16(1):105. doi: 10.1186/s12957-018-1403-9. World J Surg Oncol. 2018. PMID: 29871650 Free PMC article.

8

Oxaliplatin and capecitabine concomitant with neoadjuvant radiotherapy and extended to the resting period in high risk locally advanced rectal cancer.

Gao YH, Zhang X, An X, Cai MY, Zeng ZF, Chen G, Kong LH, Lin JZ, Wan DS, Pan ZZ, Ding PR. Gao YH, et al. Strahlenther Onkol. 2014 Feb;190(2):158-64. doi: 10.1007/s00066-013-0500-5. Epub 2014 Jan 11. Strahlenther Onkol. 2014. PMID: 24408055

9

A Feasibility Study of Neoadjuvant XELOX Without Radiotherapy for Locally Advanced Lower Rectal Cancer.

Ueki T, Manabe T, Inoue S, Ienaga J, Yamanaka N, Egami T, Ishikawa M, Konomi H, Ikubo A, Nagayoshi K, Nakamura M, Tanaka M. Ueki T, et al. Anticancer Res. 2016 Feb;36(2):741-7. Anticancer Res. 2016. PMID: 26851033 Clinical Trial.

10

Comparison of Capecitabine (Xeloda) vs. Combination of Capecitabine and Oxaliplatin (XELOX) as Neoadjuvant CRT for Locally Advanced Rectal Cancer.

Yaghobi Joybari A, Azadeh P, Babaei S, Hosseini Kamal F. Yaghobi Joybari A, et al. Pathol Oncol Res. 2019 Oct;25(4):1599-1605. doi: 10.1007/s12253-019-00587-3. Epub 2019 Feb 2. Pathol Oncol Res. 2019. PMID: 30712194 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

118 results

Results by year